<p>Community engaged dissemination and implementation (CEDI) science is a framework used to accelerate and improve the implementation of evidence-based interventions in community spaces to reduce health disparities. Currently, little is known about the relational processes in CEDI that promote healing for marginalized populations in general, and for transgender women in particular. This gap is concerning given evidence that trans women experience stark health disparities driven by structural discrimination, interpersonal victimization, and inequitable access to evidence-based services. This study aimed to elucidate CEDI specific relational processes facilitating implementation of an evidence-based violence prevention program delivered within a Black, trans women-led community setting. We leveraged qualitative data collected from intervention participants (n = 36) and facilitators (n = 3) who completed exit interviews about their perception of the process and impacts of the implemented intervention. Interviews were coded by a team of researchers to establish a reliable code-book from which a theory-driven set of themes were derived. Thematic analyses resulted in the identification of novel themes pertinent to processes facilitating and/or inhibiting effective program implementation: (1) <i>Reciprocal Love</i>; (2) <i>Facilitator Development of Cultural Humility</i>; (3) <i>Collaborative Partnerships;</i> (4) <i>Interpersonal Learning</i>; (5) <i>Community Resilience;</i> and (6) <i>Minority Stressors as Barriers to Benefit.</i> Themes were integrated into a logic model to elucidate process mechanisms hypothesized to promote intervention research outcomes. Future research on identified themes is needed to optimize outcomes in CEDI with trans women and other marginalized communities.</p><p><i>Trial Registration</i>: This study was Preregistered with Clinicaltrials.gov (ID: NCT04934189, Registered 22 June 2021, <a href="https://clinicaltrials.gov/study/NCT04934189#study-overview">https://clinicaltrials.gov/study/NCT04934189#study-overview</a>).</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Elucidating Relational Mechanisms of Community-Engaged Dissemination and Implementation with a Transgender Women Community

  • Madeleine Miller,
  • Danielle Berke

摘要

Community engaged dissemination and implementation (CEDI) science is a framework used to accelerate and improve the implementation of evidence-based interventions in community spaces to reduce health disparities. Currently, little is known about the relational processes in CEDI that promote healing for marginalized populations in general, and for transgender women in particular. This gap is concerning given evidence that trans women experience stark health disparities driven by structural discrimination, interpersonal victimization, and inequitable access to evidence-based services. This study aimed to elucidate CEDI specific relational processes facilitating implementation of an evidence-based violence prevention program delivered within a Black, trans women-led community setting. We leveraged qualitative data collected from intervention participants (n = 36) and facilitators (n = 3) who completed exit interviews about their perception of the process and impacts of the implemented intervention. Interviews were coded by a team of researchers to establish a reliable code-book from which a theory-driven set of themes were derived. Thematic analyses resulted in the identification of novel themes pertinent to processes facilitating and/or inhibiting effective program implementation: (1) Reciprocal Love; (2) Facilitator Development of Cultural Humility; (3) Collaborative Partnerships; (4) Interpersonal Learning; (5) Community Resilience; and (6) Minority Stressors as Barriers to Benefit. Themes were integrated into a logic model to elucidate process mechanisms hypothesized to promote intervention research outcomes. Future research on identified themes is needed to optimize outcomes in CEDI with trans women and other marginalized communities.

Trial Registration: This study was Preregistered with Clinicaltrials.gov (ID: NCT04934189, Registered 22 June 2021, https://clinicaltrials.gov/study/NCT04934189#study-overview).